PURPOSE: To assess the health-related quality of life (HRQOL) in an unselected sample of patients with glaucoma. METHODS: The HRQOL was studied in a cross-sectional survey in 270 patients from two departments of ophthalmology in different parts of Sweden by using the Swedish Health-Related Quality of Life Survey, a generic HRQOL-instrument adapted from the Medical Outcomes Study. RESULTS: Compared to a random Standard Population Sample, the glaucoma patients showed lower mean score only in the scale of 'Pain' (p < 0.05, effect size 0.17), but higher mean score in 'Sexual functioning' (p < 0.01, effect size 0.35). Significant factors correlated to a lower score on HRQOL-scales were decreased visual acuity and visual field, and comorbidity of cardiovascular and non-vascular systemic diseases. Regarding the topical medications, beta-blockers with or without miotic agents had no negative impact on the HRQOL. CONCLUSION: Our findings indicate that health-related quality of life in glaucoma patients in general is good, especially when vision is intact, and that topical beta-blockers do not have any negative influence.
PURPOSE: To assess the health-related quality of life (HRQOL) in an unselected sample of patients with glaucoma. METHODS: The HRQOL was studied in a cross-sectional survey in 270 patients from two departments of ophthalmology in different parts of Sweden by using the Swedish Health-Related Quality of Life Survey, a generic HRQOL-instrument adapted from the Medical Outcomes Study. RESULTS: Compared to a random Standard Population Sample, the glaucomapatients showed lower mean score only in the scale of 'Pain' (p < 0.05, effect size 0.17), but higher mean score in 'Sexual functioning' (p < 0.01, effect size 0.35). Significant factors correlated to a lower score on HRQOL-scales were decreased visual acuity and visual field, and comorbidity of cardiovascular and non-vascular systemic diseases. Regarding the topical medications, beta-blockers with or without miotic agents had no negative impact on the HRQOL. CONCLUSION: Our findings indicate that health-related quality of life in glaucomapatients in general is good, especially when vision is intact, and that topical beta-blockers do not have any negative influence.
Authors: Bradley E Dougherty; K Bradley Kehler; Richard Jamara; Nicole Patterson; Denise Valenti; Fuensanta A Vera-Diaz Journal: Optom Vis Sci Date: 2011-11 Impact factor: 1.973
Authors: John E Crews; Chiu-Fang Chou; Xinzhi Zhang; Matthew M Zack; Jinan B Saaddine Journal: Ophthalmic Epidemiol Date: 2014-06-23 Impact factor: 1.648
Authors: John E Crews; Chiu-Fang Chou; Matthew M Zack; Xinzhi Zhang; Kai McKeever Bullard; Alan R Morse; Jinan B Saaddine Journal: Ophthalmic Epidemiol Date: 2016-05-09 Impact factor: 1.648
Authors: Marcela C Cypel; Niro Kasahara; Denise Atique; Cristiano C Umbelino; Mônica P A Alcântara; Francisco S Seixas; Geraldo V de Almeida; Carmo Mandia; Ralph Cohen Journal: Int Ophthalmol Date: 2006-03-07 Impact factor: 2.031